Selling naked calls or puts can be a bad idea. Here’s why.

Selling naked calls or puts can be a bad idea. Here’s why.

May 5, 2020 | 0 comments

Just like with any speculative approach to trading, selling naked calls or puts can have its advantages and disadvantages, but one thing you should know is that a “naked” strategy is as aggressive and high risk as its name implies, with repercussions that could follow, if stop losses or other mechanisms are not used to provide some level of protection. 

In essence, a naked call or put involves the forced sale or purchase of stock or cash based futures which you don’t own. You are selling someone or buying from someone the right to an instrument at a predetermined price and for a certain amount of time, without you actually owning the instrument. 

In a naked call, when the stock rises above the strike price at expiration, the option seller is forced to buy the stock at the market price, and then sell it at the strike price, thus experiencing a loss. Anytime the owner of the call decides to exercise his/her right, you would have to purchase the asset at the predetermined price before the expiration, ending up with a short position and having to sell at a loss. Because of this, as long as the underlying asset stays below the strike price, even though profits remain limited, you are safe, however, if the price rises above the strike price, you not only forfeit profiting from the premium, but losses can add up quickly and without limit. You can see why limited profits versus unlimited risk might be an unattractive concept. 

A naked put carries slightly lower risk than a naked call, however, the strategy still has limited potential gain, and significant potential loss. Let’s say you execute a naked put by selling a put option with a strike price lower than the market price. If the stock expires at a price lower than the strike price, and the option is exercised, the seller of the put option is obligated to buy shares of the stock at the strike price instead of at the lower market price. You would write a naked put option when you expect the asset to trade above the strike price at expiration, but the risk from this strategy heavily outweighs its potential rewards.

Just like with covered calls, naked calls are sometimes recommended to be written when stock prices are moving down and puts when stock prices are moving up in order to improve your probability of profiting.

You might be enticed by the promise of big wins, and while a naked strategy can be used successfully as part of a diversified portfolio to generate significant income, it can also have devastating results well beyond your portfolio. You see, buying naked exposes you to unlimited risk and unlimited losses, requires high margins, and places you in a position where the market can move against you rapidly and considerable swings in price can cause significant amounts of drawdown to your account. With the unbalanced risk versus reward of naked calls and puts, we recommend a solid money management strategy and risk control. 

Even the most savvy and knowledgeable investors, with nerves of steel and solid risk management strategies, offset their risk when trading naked options by purchasing another underlying asset or call. This strategy utilizing covered calls and covered puts, can potentially allow you to increase profits and limit losses, hence balancing out the risky approach of trading naked.  


Submit a Comment

Your email address will not be published. Required fields are marked *


  • Tenable To Buy Accurics For About $160 Mln In Cash - Quick Facts September 13, 2021
    (RTTNews) - Tenable Holdings Inc. (TENB) said that it agreed to buy Accurics for a total purchase price of about $160 million in cash, subject to certain customary purchase price adjustments. The acquisition is expected to close late in the third quarter or early in the fourth quarter of 2021. Following the completion of the […]
  • Farmmi, Inc. Prices $81 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares September 13, 2021
    LISHUI, China, Sept. 13, 2021 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier in China, today announced the pricing of an underwritten public offering of ordinary shares and...
  • 3 Stocks Insiders Are Buying September 13, 2021
    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases...
  • MiMedx: Phase 3 PF Study Fails To Meet Primary Endpoint; To Pursue Phase 3 KOA Confirmatory Studies September 13, 2021
    (RTTNews) - MiMedx Group, Inc. (MDXG) reported top-line results from two late-stage musculoskeletal clinical trials of its micronized dehydrated Human Amnion Chorion Membrane: a phase 2B clinical trial for the treatment of Knee Osteoarthritis and a phase 3 clinical trial for the treatment of Plantar Fasciitis. The phase 3 Plantar Fasciitis study...
  • AbbVie Inks Eye Care Deal With REGENXBIO September 13, 2021
    (RTTNews) - Lake Bluff-based biopharmaceutical company AbbVie (ABBV) has joined hands with Rockville-headquartered REGENXBIO Inc. (RGNX), a clinical-stage biotechnology firm to develop and sell RGX-314, an eye-care therapy, the companies said in a statement on Monday. RGX-314 is a potential one-time gene therapy for the treatment of wet...